Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups

de Witte, T.; Hagemeijer, Anne; Suciu, Stefan; Belhabri, A; Delforge, Michel; Aul, C; Aivado, M; Selleslag, D.; Schouten, H; Ferrant, Augustin; Biersack, H; Amadori, S.; Muus, P.; Jehn, U.; Beeldens, F.; Jansen, J; Hellstrom-Lindberg, P; Ossenkoppele, G; Gratwohl, A.; Marie, JP

doi:10.1038/sj.bmt.1705323

Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups

de Witte, T.

;

Hagemeijer, Anne

;

Suciu, Stefan

;

Belhabri, A

;

Willemze, R.

;et.al.

(2006) 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group — Location: Hamburg (Germany) (19.March.2006)

Files

No attached file found for this publication.

Details

Authors

de Witte, T.
Author
Hagemeijer, Anne
Author
Suciu, StefanUCLouvain
Author
Belhabri, A
Author
Ferrant, AugustinUCLouvain
Author
Willemze, R.
Author

Affiliations

UCLouvain

Citations

APA
Chicago
FWB

de Witte, T., Hagemeijer, A., Suciu, S., Belhabri, A., Delforge, M., Aul, C., Aivado, M., Selleslag, D., Schouten, H., Ferrant, A., Biersack, H., Amadori, S., Muus, P., Jehn, U., Beeldens, F., Jansen, J., Hellstrom-Lindberg, P., Ossenkoppele, G., Gratwohl, A., et al. (2006). Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups. Bone Marrow Transplantation, 37, S1-S1. https://doi.org/10.1038/sj.bmt.1705323 (Original work published 2006)